Tube Investments of India forays into pharma sector
The company will engage in contract manufacturing, research and development of API
Global Pharma | 15/03/2023 | By Sudeep Soparkar | 1398
Mettler-Toledo Product Inspection unveils personalised virtual factory tours
Guided virtual tours for solid and liquid pharmaceutical production allow manufacturers to discuss bespoke needs and compliance with quality and safety demands
<br />
Global Pharma | 14/03/2023 | By Sudeep Soparkar | 970
Markus Schmidt Named CEO of BEUMER Corporation
BEUMER Corporation, the wholly owned U.S. subsidiary of Beckum, Germany-based BEUMER Group, has named Markus Schmidt as president and chief executive officer.
Global Pharma | 03/03/2023 | By Sudeep Soparkar | 993
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products
Global Pharma | 27/02/2023 | By Sudeep Soparkar | 1332
ADCAN Pharma in Abhu Dhabi commences operations
ADCAN Pharma's factory is built on a plot of 31,000 square meters within the ICAD area
<br />
Global Pharma | 23/02/2023 | By Sudeep Soparkar | 2222
Shilpa Medicare registers Bengaluru facility with Ministry of Health, UAE
The facility is involved in the manufacturing and testing of specialized dosage forms eg. Orodispersible Films and Transdermal systems
Global Pharma | 20/02/2023 | By Sudeep Soparkar | 1303
Australia-headquartered Novotech to acquire EastHORN
The acquisition is part of Novotech's global expansion programme
Global Pharma | 17/01/2023 | By Sudeep Soparkar | 1281
The lab will be a dedicated facility for integrated discovery work streams including medicinal and synthetic chemistry, in vitro biology, and process chemistry
Global Pharma | 11/01/2023 | By Sudeep Soparkar | 1806
PIRC will be equipped with a state-of-the-art lab featuring cutting-edge technology to support the identification and development of therapeutic opportunities
Global Pharma | 09/01/2023 | By Sudeep Soparkar | 1012
Polysciences creates new bioprocessing brand, Kyfora Bio
Based in Horsham, PA, Kyfora Bio will occupy a 45,000 sq ft cGMP facility with administrative offices, R&D labs, manufacturing suites
Global Pharma | 03/01/2023 | By Sudeep Soparkar | 632
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy